Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.6%

9 terminated/withdrawn out of 85 trials

Success Rate

83.0%

-3.5% vs industry average

Late-Stage Pipeline

4%

3 trials in Phase 3/4

Results Transparency

2%

1 of 44 completed trials have results

Key Signals

5 recruiting1 with results5 withdrawn

Enrollment Performance

Analytics

N/A
29(67.4%)
Phase 2
7(16.3%)
Phase 1
4(9.3%)
Phase 3
2(4.7%)
Phase 4
1(2.3%)
43Total
N/A(29)
Phase 2(7)
Phase 1(4)
Phase 3(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (85)

Showing 20 of 85 trials
NCT05145023Completed

Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis

Role: collaborator

NCT07289100Recruiting

Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis

Role: lead

NCT07267936Not ApplicableRecruiting

Interventions for Maximizing Patient And Family Smoking Cessation Together

Role: lead

NCT06433960Completed

Radial Artery Assessment in Surgical Coronary Revascularisation

Role: lead

NCT06386185Recruiting

Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography

Role: collaborator

NCT06222905Active Not Recruiting

Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)

Role: lead

NCT04266873Not ApplicableSuspended

Feasibility Study of the AffloVest in Bronchiectasis

Role: lead

NCT02912637Withdrawn

Hyperpolarized Xenon Imaging in Patients With Cystic Fibrosis

Role: lead

NCT05308719Not ApplicableCompleted

Nasal Oxygen Therapy After Cardiac Surgery

Role: lead

NCT05944367Completed

The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis

Role: lead

NCT05941832Completed

ANNE Sensor Monitoring in Cystic Fibrosis

Role: lead

NCT06685874Active Not Recruiting

Interstitial Lung Disease Exacerbations Study

Role: collaborator

NCT02526004Not ApplicableCompleted

Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified

Role: collaborator

NCT04435249Phase 1Withdrawn

ENgineered Tissue Repair of BronchopleUral FiSTula

Role: collaborator

NCT06844370Not ApplicableRecruiting

Home Versus Hospital Based NIV Care in MND

Role: lead

NCT05648227Active Not Recruiting

Validation of an Artificial Intelligence Enabled Diagnostic Support Software (ArtiQ.Spiro) in Primary Care Spirometry Datasets - a Retrospective Analysis

Role: collaborator

NCT04231461Completed

Quality of Life After Cardiac Surgery

Role: lead

NCT06145880Withdrawn

ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and Echo

Role: collaborator

NCT02304276Not ApplicableCompleted

18F-Fluoride Assessment of Aortic Bioprosthesis Durability and Outcome

Role: collaborator

NCT06421792Not Yet Recruiting

PrOtamIne doSing clOt imagiNg (POISON) Study

Role: lead